ArticleLiver international : official journal of the International Association for the Study of the Liver2026
Threshold-Defined Liver Stiffness Trajectories and Liver-Related Event Risk in Chronic Liver Disease: A Cohort Study.
Article in Liver international : official journal of the International Association for the Study of the Liver, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Threshold-Defined Liver Stiffness Trajectories and Liver-Related Event Risk in Chronic Liver Disease: A Cohort Study.Liver international : official journal of the International Association for the Study of the Liver · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
BACKGROUND &
aimsVibration-controlled transient elastography (VCTE) predicts liver-related events (LREs), but how serial liver stiffness (LS) changes should be translated into clinical risk-whether by their magnitude, direction or movement across established thresholds-remains uncertain. We tested whether a threshold-defined trajectory framework anchored at the Baveno VII 10 kPa criterion would stratify LRE risk across chronic liver disease aetiologies.
methodsFrom the retrospective V-LINK registry (2006-2020), 6313 event-free patients with baseline and 1-year LS were stratified by the 10 kPa threshold into Stable Low, Improved, Worsened or Persistent High trajectories. A 3-year landmark (LM3) subset (n = 1617) enabled trajectory reassessment over time. Cox models estimated adjusted hazard ratios (HRs).
resultsDuring a median follow-up of 5.5 years, 472 LREs occurred. Compared with Stable Low, adjusted HRs were 1.5 (95% confidence interval [CI], 1.1-2.2) for Improved, 2.5 (1.5-4.3) for Worsened and 4.1 (3.1-5.5) for Persistent High, with 3-year risks of 1.2%, 3.2%, 3.8%, and 15.0%. Persistent High (14.4% of the cohort) accounted for 61.9% of LREs; 65.7% showed a numerical decrease in LS yet remained ≥ 10 kPa. By aetiology, the HR for Persistent High was 6.4 (4.0-10.2) in non-viral aetiologies versus 2.6 (1.8-3.8) in viral aetiologies (p for interaction < 0.001). At LM3, the trajectory-based risk gradient was preserved (Persistent High HR, 3.5; 95% CI, 2.2-5.5).
conclusionsThreshold-defined LS trajectories identified a small subgroup concentrating most LRE risk, with the largest gradient in non-viral aetiologies. Persistent threshold elevation was the most robust prognostic signal, supporting serial LS monitoring pending external validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.